Sep 20, 2026 · 1h 21m
Peter Rahal bets on speed, control and product mastery
Building One of the Fastest Growing CPG Companies in History | Peter Rahal of David Protein, Medici Brands & RXBAR
Rahal’s return from the RXBAR exit to building David shows how ambition, supply-chain control and organizational design shape a consumer company’s next stage.
- 1Rahal returned to operating after investing exposed how poorly he fit the sidelines.
- 2David treats brand identity, product quality and protein expertise as long-term strategic assets.
- 3Medici decentralizes decision-making while preserving control over talent, culture and critical supply.
Don't miss
Rahal explains how acquiring Apogee secured a scarce patented ingredient and let David shut off supply to competing companies.
The brief
After selling RXBAR for $600 million, Peter Rahal tried investing and a family-office model before concluding that his temperament demanded operating again.
Rahal frames David as the first wedge in a much larger food company: make familiar foods smarter, then build a brand with a durable human identity.
His account of dyslexia, resentment and adversity is not a side story; he presents those forces as fuel for discipline, competition and relentless problem-solving.
The Apogee acquisition shows the strategy in practice: David secured a critical patented ingredient, then used supply control to strengthen its position.
Rahal’s Medici structure gives semi-autonomous units authority while shared functions preserve alignment, allowing speed without abandoning product mastery or organizational standards.
